H.
LIVE

Serial Number

88661521

Owner

HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY

Attorney

Deborah L. Corpus

First Use Date

Jun 28, 2018

Filing Date

Oct 20, 2019

Add to watchlist:

No watchlists yet
View on USPTO

H. Trademark

Serial Number: 88661521 • Registration: 6058341

H. is a trademark filed by HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY on October 20, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently registered and active.

Owner Contact Info

HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY (5 trademarks)

1 New Burlington Place
London W1S2HR , GB

Entity Type: 99

Trademark Details

Filing Date

October 20, 2019

Registration Date

May 19, 2020

First Use Anywhere

June 28, 2018

First Use in Commerce

June 28, 2018

Published for Opposition

March 3, 2020

Goods & Services

[ Custom manufacture of pharmaceutical preparations and substances for others ]

Pharmaceutical, medicinal, and veterinary preparations and substances, namely, systemic anti-infectives; Pharmaceutical and medicinal substances for the prevention, curing, and treatment of viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders; Pharmaceutical and medicinal substances for the prevention, curing, and treatment of allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, alimentary, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, parasitic, psychiatric, and immune system related diseases and disorders, allergies, inflammation, pain, infectious diseases, blood diseases and disorders, nervous system diseases and disorders, malignant neoplastic diseases and disorders, and immunomodulating agent diseases and disorders

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 20, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 20, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 18, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 25, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 19, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
May 19, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 24, 2020 XAEC
ASSIGNED TO LIE
Jan 24, 2020 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 24, 2020 CNEA
ASSIGNED TO EXAMINER
Jan 24, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2019 NWOS
NEW APPLICATION ENTERED
Oct 23, 2019 NWAP